Engineered adeno-associated virus vector yields high transduction of the brain vasculature

Researchers have developed an engineered adeno-associated virus (AAV) vector that yields high transduction of brain vascular pericytes and smooth muscle cells.

Monumental $11.5 million gift will enable FAU to find a cure for amyloidosis

Currently, there is no cure for amyloidosis, a life-threatening disease that can be present throughout the body, including the heart, kidneys, liver and brain. The

July 13, 2023

Study sheds light on how traumatic memories are created

Scientists have long speculated about the physical changes that occur in the brain when a new memory is formed. Now, research from the National Institute

October 12, 2023

bioXcelerate launches breakthrough AI tool for faster drug discovery

bioXcelerate, a new and innovative health data science division of Optima Partners Limited, has revealed a new groundbreaking AI tool, which is set to accelerate

March 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.